Rare diseases
Investigational molecules
Locations
Back to Norway534 clinical trials in Oslo, Norway across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
NorwayA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
NorwayPhase II study of intratumoral getacatetide in patients with locally advanced or metastatic adrenocortical carcinoma
NorwayTicagrelor, Acetylsalicylic Acid and Prasugrel in Patients with Acute Coronary Syndrome: A Study of Antiplatelet Management
NorwayA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
NorwayZodasiran for Adolescents With Homozygous Familial Hypercholesterolemia: A Phase 3 Study of Efficacy and Safety
NorwayEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
NorwayComparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
NorwayStudy of BMS-986504 alone or in drug combination in adults with advanced or metastatic solid tumors with MTAP deletion
NorwayRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
NorwayRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
NorwayPhase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies
NorwayThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary conditions and respiratory health, including studies on idiopathic pulmonary fibrosis and respiratory syncytial virus prevention in children.
Innovative therapies being tested to improve lung function and patient outcomes.
Studies examining heart conditions and vascular health, with particular focus on heart failure and cardiovascular disease prevention.
Advanced imaging techniques and therapeutic interventions being evaluated for cardiac conditions.
Comprehensive research into various cancer treatments, including trials for gastric, esophageal, and rare cancers.
Novel therapeutic approaches combining immunotherapy with conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
